Bryn Mawr Capital Management’s Akari Therapeutics AKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-5,000
| Closed | -$17K | – | 394 |
|
|
2023
Q2 | $17K | Hold |
5,000
| – | – | ﹤0.01% | 282 |
|
|
2023
Q1 | $18.2K | Hold |
5,000
| – | – | ﹤0.01% | 267 |
|
|
2022
Q4 | $47K | Hold |
5,000
| – | – | 0.01% | 263 |
|
|
2022
Q3 | $63K | Hold |
5,000
| – | – | 0.02% | 137 |
|
|
2022
Q2 | $100K | Hold |
5,000
| – | – | 0.03% | 149 |
|
|
2022
Q1 | $120K | Hold |
5,000
| – | – | 0.03% | 158 |
|
|
2021
Q4 | $150K | Buy |
+5,000
| New | +$150K | 0.06% | 107 |
|